(Q38309221)

2 September 2017

Silencing of CD44 expression in prostate cancer by hypermethylation of the CD44 promoter region (English)

1 reference

2 September 2017

1 reference

1 reference

Verkaik NS

1

1 reference

2 September 2017

van Steenbrugge GJ

2

1 reference

2 September 2017

van Weerden WM

3

1 reference

2 September 2017

Bussemakers MJ

4

1 reference

2 September 2017

van der Kwast TH

5

1 reference

2 September 2017

1 August 2000

1 reference

2 September 2017

Laboratory Investigation

1 reference

2 September 2017

80

1 reference

2 September 2017

8

1 reference

2 September 2017

1291-1298

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3780137

2 September 2017

0 references

cites work

CD44 and CD44v6 downregulation in clinical prostatic carcinoma: relation to Gleason grade and cytoarchitecture.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

How does DNA methylation repress transcription?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

Methyl-CpG-binding protein MeCP2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

CpG methylation, chromatin structure and gene silencing-a three-way connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

CD44 is the principal cell surface receptor for hyaluronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

7 January 2021

Prostate-specific antigen: its clinical use and application in screening for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

7 January 2021

PSA screening for prostate cancer: the current controversy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

7 January 2021

Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

7 January 2021

CD44: structure, function, and association with the malignant process.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

7 January 2021

Decreased expression of CD44 in metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

7 January 2021

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

7 January 2021

Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

7 January 2021

CD44 as a marker in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

7 January 2021

Splicing choice from ten variant exons establishes CD44 variability

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

7 January 2021

Down-regulation of CD44 expression in human prostatic carcinoma cell lines is correlated with DNA hypermethylation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

7 January 2021

Overdiagnosis of prostate carcinoma by screening: an estimate based on the results of the Florence Screening Pilot Study

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780137

7 January 2021

10.1038/LABINVEST.3780137

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference